title: Reliability and validity of the CMT neuropathy score as a measure of disability.
abstract: OBJECTIVE
  To determine the validity and reliability of the Charcot-Marie-Tooth disease (CMT) neuropathy score (CMTNS) in patients with inherited neuropathy.
  
  
  BACKGROUND
  Natural history studies and potential treatment trials for patients with various forms of CMT are limited by the lack of quantitative methodologies to monitor disease progression. Most cases of CMT can be considered length-dependent axonal neuropathies because disability for even the demyelinating forms correlates with length-dependent axonal degeneration. The total neuropathy score (TNS) is a validated composite measure of disability in length-dependent axonal neuropathies but is weighted toward predominantly sensory neuropathies. Thus, the authors have devised a CMTNS, modified from the TNS, to provide a single measure to quantify CMT disability.
  
  
  METHODS
  The authors measured inter- and intrainvestigator reliability of the CMTNS and performed a validation of the score with the Neuropathy Impairment Score (NIS), patient self-assessment scores, an ambulation index, and other measures of disability.
  
  
  RESULTS
  Inter- and intrainvestigator reliability was more than 95% in the 60 patients evaluated. Patients could be divided into mild (CMTNS, < or =10), moderate (CMTNS, 11 to 20), and severe (CMTNS, > or =21) categories and demonstrated excellent correlations among all measures of disability.
  
  
  CONCLUSIONS
  The Charcot-Marie-Tooth disease (CMT) neuropathy score is a validated measure of length-dependent axonal and demyelinating CMT disability and can be investigated as an end point for longitudinal studies and clinical trials of CMT.
authors.affiliation: Department of Neurology, Wayne State University, Detroit, MI 48201, USA. m.shy@wayne.edu
authors.forename: M E
authors.initials: ME
authors.lastname: Shy
authors.forename: J
authors.initials: J
authors.lastname: Blake
authors.forename: K
authors.initials: K
authors.lastname: Krajewski
authors.forename: D R
authors.initials: DR
authors.lastname: Fuerst
authors.forename: M
authors.initials: M
authors.lastname: Laura
authors.forename: A F
authors.initials: AF
authors.lastname: Hahn
authors.forename: J
authors.initials: J
authors.lastname: Li
authors.forename: R A
authors.initials: RA
authors.lastname: Lewis
authors.forename: M
authors.initials: M
authors.lastname: Reilly
mesh_terms: D000200:Action Potentials / Q000235:genetics; D002607:Charcot-Marie-Tooth Disease / Q000175:diagnosis* / Q000503:physiopathology; D015331:Cohort Studies; D004185:Disability Evaluation; D018450:Disease Progression; D004568:Electrodiagnosis / Q000379:methods*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D006801:Humans; D008475:Median Nerve / Q000503:physiopathology; D009431:Neural Conduction / Q000235:genetics*; D009460:Neurologic Examination / Q000379:methods; D015588:Observer Variation; D010525:Peripheral Nerves / Q000503:physiopathology*; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D014459:Ulnar Nerve / Q000503:physiopathology